AI Summary
Thinking
We reviewed 3 live results for l01cd04 and narrowed them down to the 3 options that look most worth comparing first.
The options are Cabazitaxel Fresenius Kabi 20 mg / ml concentrate for solution for infusion, JEVTANA 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION and Cabazitaxel EVER Pharma 10 mg / ml concentrate for solution for infusion.
Source: Unknown source
Description
Cabazitaxel Fresenius Kabi 20 mg / ml concentrate for solution for infusion is an authorised human prescription medicine containing the active substance cabazitaxel under ATC code L01CD04. Held by Fresenius Kabi Deutschland GmbH under licence PA2059/082/001, this medicinal product is subject to restricted medical prescription and pharmacy-only supply, with marketing availability listed as not marketed.
Rate this product
Source: Unknown source
Description
JEVTANA 60 mg concentrado y disolvente para solución para perfusión es un medicamento de uso hospitalario comercializado por SANOFI AVENTIS, S.A., formulado con el principio activo cabazitaxel (L01CD04). Está indicado para el tratamiento del cáncer de próstata resistente a la castración metastásico (CPRCm). Su presentación contiene un vial de concentrado de 1,5 ml y un vial de disolvente de 4,5 ml bajo prescripción médica.
Best for
pacientes con cáncer de próstata resistente a la castración metastásico and tratamiento oncológico hospitalario
Rate this product
Source: Unknown source
Description
Cabazitaxel EVER Pharma 10 mg / ml concentrate for solution for infusion is an authorised human prescription medicine holding licence PA1774/004/001 from the Health Products Regulatory Authority (HPRA) in Ireland. Formulated with the active substance cabazitaxel under ATC classification L01CD04, this marketed product is held by EVER Valinject GmbH and is subject to restricted, non-renewable medical prescription with supply strictly restricted to pharmacies.
Best for
oncology patients, healthcare professionals, intravenous chemotherapy infusion and restricted hospital or pharmacy medical prescription treatment
Rate this product
| Compare | #1Cabazitaxel Fresenius Kabi 20 mg / ml concentrate for solution for infusion | #2JEVTANA 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION | #3Cabazitaxel EVER Pharma 10 mg / ml concentrate for solution for infusion |
|---|---|---|---|
| Source | Unknown source | Unknown source | Unknown source |
| Description | Cabazitaxel Fresenius Kabi 20 mg / ml concentrate for solution for infusion is an authorised human prescription medicine containing the active substance cabazitaxel under ATC code L01CD04. Held by Fresenius Kabi Deutschland GmbH under licence PA2059/082/001, this medicinal product is subject to restricted medical prescription and pharmacy-only supply, with marketing availability listed as not marketed. | JEVTANA 60 mg concentrado y disolvente para solución para perfusión es un medicamento de uso hospitalario comercializado por SANOFI AVENTIS, S.A., formulado con el principio activo cabazitaxel (L01CD04). Está indicado para el tratamiento del cáncer de próstata resistente a la castración metastásico (CPRCm). Su presentación contiene un vial de concentrado de 1,5 ml y un vial de disolvente de 4,5 ml bajo prescripción médica. | Cabazitaxel EVER Pharma 10 mg / ml concentrate for solution for infusion is an authorised human prescription medicine holding licence PA1774/004/001 from the Health Products Regulatory Authority (HPRA) in Ireland. Formulated with the active substance cabazitaxel under ATC classification L01CD04, this marketed product is held by EVER Valinject GmbH and is subject to restricted, non-renewable medical prescription with supply strictly restricted to pharmacies. |
| Best for | pacientes con cáncer de próstata resistente a la castración metastásico and tratamiento oncológico hospitalario | oncology patients, healthcare professionals, intravenous chemotherapy infusion and restricted hospital or pharmacy medical prescription treatment | |
| Action | Cabazitaxel Fresenius Kabi 20 mg / ml concentrate for solution for infusion | JEVTANA 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION | Cabazitaxel EVER Pharma 10 mg / ml concentrate for solution for infusion |
| Rate this product |
"Cabazitaxel Fresenius Kabi 20 mg / ml concentrate for solution for infusion."
Note: TopFind AI compiles product and service information for general comparison purposes only.